Joint Program Executive Office for Chemical and Biological Defense ...
Joint Program Executive Office for Chemical and Biological Defense ...
Joint Program Executive Office for Chemical and Biological Defense ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
• Anticipate 2QFY14 contract award<br />
‒ Phase 2 human clinical safety study<br />
‒ Toxicology <strong>and</strong> definitive animal efficacy studies<br />
‒ Manufacturer of improved oxime <strong>and</strong> delivery system<br />
‒ Studies to support exp<strong>and</strong>ed pretreatment indications <strong>for</strong> PB<br />
• As funding permits, explore opportunities <strong>for</strong> dual prototyping <strong>and</strong><br />
improvements to the existing nerve agent treatment regimen through task<br />
order vehicles <strong>and</strong> CBMS BAA (CBMS-BAA-07-01)<br />
‒ Studies to refine the MMB4 enhanced <strong>for</strong>mulation<br />
‒ Studies to evaluate c<strong>and</strong>idate oximes in support of oxime risk mitigation strategy<br />
with international partners<br />
‒ Studies to investigate auto-injector refinements<br />
20121115 CBMS-MITS INATS Mobley<br />
Business Opportunities<br />
UNCLASSIFIED<br />
9
Change language